F15 - Risk Mitigation in Mixed SBER and Biomedical Research—A Case-Based Approach

Friday, November 19, 2021

1:30 PM – 2:30 PM ET

Location: On-Demand

Using case studies to highlight common challenge areas and spur discussion, this session will focus on risk mitigation in research involving both biomedical and social science methods. Case study topics forthcoming. Before attending this session, attendees should have a basic foundation in human research protections ethics and regulations, including the criteria for approval and definitions from DHHS and FDA regulations.

Learning Objectives:

Review the nature of potential harms associated with mixed social behavioral and biomedical research
Explore factors likely to contribute to increased risk in this context
Discuss how to design research with sufficient protections to mitigate risks

Presenter(s)

Lara N. Sloboda, PhD

Dana Farber Cancer Insititute
Boston, MA
Matt Stafford, MPH

Boston Children's Hospital
Harvard Catalyst
Boston, MA